The DOI matches its Crossref record.
Antibody to the α4 Integrin Decreases Infarct Size in Transient Focal Cerebral Ischemia in Rats
Open accessAbstract
Background and Purpose —Inflammation, a process that involves neutrophils, lymphocytes, and monocytes, contributes to cerebral ischemic injury. Blockade of neutrophil adhesion to endothelium improves outcome after experimental stroke. In this study we sought to assess the contribution of lymphocytes and monocytes to ischemic brain injury. Methods —Male Lewis rats underwent 3 hours of middle cerebral artery occlusion followed by 45 hours of reperfusion. Two hours after the onset of ischemia, one group of animals received an intraperitoneal injection of antibodies to the α 4 integrin (n=16); another group was injected with an isotype control antibody (n=11). Neurological examination, body temperature, and body weight were assessed at different time points after stroke. Animals were killed 48 hours after the onset of ischemia for determination of infarct volume and leukocyte counts. Results —There were no significant differences in body temperature or weight at any time. Neurological scores (deficits) were significantly less in animals treated with anti-α 4 antibodies at 24 (2.0±1.2 versus 3.0±0.4; P =0.006) and 48 (2.0±1.2 versus 3.0±0.8; P =0.011) hours after ischemia. Peripheral blood leukocyte counts were significantly higher in anti-α 4 –treated animals (6.8±2.2×10 9 versus 2.9±1.9×10 9 ; P =0.001) and revealed a lymphocyte/monocyte predominance (86.0±16.2% versus 71.0±15.6%; P =0.008). Infarct volume was significantly less in animals treated with antibodies to α 4 (120.1±51.21 versus 173.7±42.29 mm 3 ; P =0.012). Conclusions —These data support a role for lymphocytes and monocytes in cerebral ischemic injury and show that blockade of α 4 , even when instituted after the onset of ischemia, can improve neurological outcome and decrease infarct volume.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
The inflammatory response in stroke
Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,177
Paul, S., & Candelario-Jalil, E. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113518 · Cited by 748
Jurcau, A., & Simion, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010014 · Cited by 500
Cerebral ischemia and inflammation
Iadecola, C., & Alexander, M. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200102000-00014 · Cited by 466
Liesz, A., Zhou, W., Mracskó, É., Karcher, S., Bauer, H., Schwarting, S., Sun, L., Bruder, D., Stegemann, S., Cerwenka, A., et al. (2011) · Brain · doi:10.1093/brain/awr008 · Cited by 411
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Frijns, C. J. M., & Kappelle, L. J. (2002) · Stroke · doi:10.1161/01.str.0000021902.33129.69 · Cited by 390
Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
Kleinschnitz, C., Schwab, N., Kraft, P., Hagedorn, I., Dreykluft, A., Schwarz, T., Austinat, M., Nieswandt, B., Wiendl, H., & Stoll, G. (2010) · Blood · doi:10.1182/blood-2009-10-249078 · Cited by 358
T- and B-Cell-Deficient Mice with Experimental Stroke have Reduced Lesion Size and Inflammation
Hum, P. D., Subramanian, S., Parker, S. M., Afentoulis, M. E., Kaler, L. J., Vandenbark, A. A., & Offner, H. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600482 · Cited by 355
Thrombo-inflammation in acute ischaemic stroke — implications for treatment
Stoll, G., & Nieswandt, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0221-1 · Cited by 332
Pathophysiology of Stroke: Lessons from Animal Models
Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043966.46964.e6 · Cited by 325
Thromboinflammation in Stroke Brain Damage
De Meyer, S. F., Denorme, F., Langhauser, F., Geuss, E., Fluri, F., & Kleinschnitz, C. (2016) · Stroke · doi:10.1161/strokeaha.115.011238 · Cited by 312
Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells
Kim, J. Y., Park, J., Chang, J. Y., Kim, S.-H., & Lee, J. E. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.241 · Cited by 309
Microglia in ischemic brain injury
Weinstein, J. R., Koerner, I. P., & Möller, T. (2009) · Future Neurology · doi:10.2217/fnl.10.1 · Cited by 272
Bai, J., & Lyden, P. D. (2015) · International Journal of Stroke · doi:10.1111/ijs.12434 · Cited by 270
Inflammatory Responses in Brain Ischemia
Kawabori, M., & Yenari, M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209154036 · Cited by 262
Llovera, G., Hofmann, K., Roth, S., Salas-Pérdomo, A., Ferrer-Ferrer, M., Perego, C., Zanier, E. R., Mamrak, U., Rex, A., Party, H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9853 · Cited by 253
Elkins, J., Veltkamp, R., Montaner, J., Johnston, S. C., Singhal, A. B., Becker, K., Lansberg, M. G., Tang, W., Chang, I., Muralidharan, K., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30357-x · Cited by 224
Self-citationIntegrins as receptor targets for neurological disorders
Wu, X., & Reddy, D. S. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.008 · Cited by 175
Enzmann, G., Kargaran, S., & Engelhardt, B. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418794184 · Cited by 119
Metadata
- Authors
- Becker, K., Kindrick, D., Relton, J., Harlan, J., & Winn, R.
- Venue
- Stroke
- Published
- 2001-01
- Volume
- 32
- Issue
- 1
- Pages
- 206-211
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2114806898
- Cited by
- 168
- References
- 0
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.